Epigenetic regulation of EBV and KSHV latency

Current Opinion in Virology

Volumn 3, Issue 3, 2013, Pages 251-259

  Chen, Horng Shen ^a   Lu, Fang ^a   Lieberman, Paul M ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; HOST FACTOR; LATENCY ASSOCIATED NUCLEAR ANTIGEN; RNA POLYMERASE II; TATA BINDING PROTEIN; TATA BINDING PROTEIN ASSOCIATED FACTOR; VIRUS DNA;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL SURVIVAL; CHROMATIN; CHROMATIN STRUCTURE; CHROMOSOME; CONFORMATION; DNA DAMAGE; DNA METHYLATION; DNA REPLICATION; DNA STRUCTURE; EPIGENETIC REPRESSION; EPIGENETICS; EPSTEIN BARR VIRUS; GENE EXPRESSION; HERITABILITY; HISTONE MODIFICATION; HOST CELL; HUMAN HERPESVIRUS 8; IMMEDIATE EARLY GENE; IMMUNOCOMPETENT CELL; INTERACTIONS WITH DNA; METAPHASE CHROMOSOME; METHYLATION; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEOSOME; PATHOGENESIS; PLASTICITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; PROTEOMICS; SISTER CHROMATID; STABLE EXPRESSION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR BIOPSY; VIRUS GENE; VIRUS GENOME;

EID: 84880279898     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2013.03.004     Document Type: Review

References (113)

1. M. Rowe, A.L. Lear, D. Croom-Carter, A.H. Davies, and A.B. Rickinson Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes J Virol 66 1992 122 131
2. M. Takacs, J. Segesdi, F. Banati, A. Koroknai, H. Wolf, H.H. Niller, and J. Minarovits The importance of epigenetic alterations in the development of Epstein-Barr virus-related lymphomas Mediterr J Hematol Infect Dis 1 2009 e2009012
3. S.N. Pantry, and P.G. Medveczky Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication Semin Cancer Biol 19 2009 153 157
4. F.D. Fakhari, and D.P. Dittmer Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR J Virol 76 2002 6213 6223
5. R.G. Jenner, M.M. Alba, C. Boshoff, and P. Kellam Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays J Virol 75 2001 891 902
6. M. Paulose-Murphy, N.K. Ha, C. Xiang, Y. Chen, L. Gillim, R. Yarchoan, P. Meltzer, M. Bittner, J. Trent, and S. Zeichner Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus) J Virol 75 2001 4843 4853
7. H. Li, T. Komatsu, B.J. Dezube, and K.M. Kaye The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter J Virol 76 2002 11880 11888
8. M. Pearce, S. Matsumura, and A.C. Wilson Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter J Virol 79 2005 14457 14464
9. R.G. Nador, L.L. Milligan, O. Flore, X. Wang, L. Arvanitakis, D.M. Knowles, and E. Cesarman Expression of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor monocistronic and bicistronic transcripts in primary effusion lymphomas Virology 287 2001 62 70
10. L.R. Dresang, J.R. Teuton, H. Feng, J.M. Jacobs, D.G. Camp 2nd, S.O. Purvine, M.A. Gritsenko, Z. Li, R.D. Smith, and B. Sugden Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes BMC Genomics 12 2011 625
11. D.P. Dittmer Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays Cancer Res 63 2003 2010 2015
12. P. Trivedi, K. Takazawa, C. Zompetta, L. Cuomo, E. Anastasiadou, A. Carbone, S. Uccini, F. Belardelli, K. Takada, and L. Frati Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression Blood 103 2004 313 316
13. L. Fassone, K. Bhatia, M. Gutierrez, D. Capello, A. Gloghini, R. Dolcetti, D. Vivenza, V. Ascoli, F. Lo Coco, and L. Pagani Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma Leukemia 14 2000 271 277
14. Q. Tao, L.J. Swinnen, J. Yang, G. Srivastava, K.D. Robertson, and R.F. Ambinder Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease, Application of PCR-based analysis Am J Pathol 155 1999 619 625
15. K.D. Robertson, A. Manns, L.J. Swinnen, J.C. Zong, M.L. Gulley, and R.F. Ambinder CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease Blood 88 1996 3129 3136
16. R.F. Ambinder, K.D. Robertson, and Q. Tao DNA methylation and the Epstein-Barr virus Semin Cancer Biol 9 1999 369 375
17. J. Minarovits Epigenotypes of latent herpesvirus genomes Curr Top Microbiol Immunol 310 2006 61 80
18. G. Fejer, A. Koroknai, F. Banati, I. Gyory, D. Salamon, H. Wolf, H.H. Niller, and J. Minarovits Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus J Gen Virol 89 2008 1364 1370
19. A. Bakos, F. Banati, A. Koroknai, M. Takacs, D. Salamon, S. Minarovits-Kormuta, F. Schwarzmann, H. Wolf, H.H. Niller, and J. Minarovits High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1 Virus Genes 35 2007 195 202
20. G. Smuk, A. Illes, K. Keresztes, L. Kereskai, B. Marton, Z. Nagy, A. Lacza, and L. Pajor Pheno- and genotypic features of Epstein-Barr virus associated B-cell lymphoproliferations in peripheral T-cell lymphomas Pathol Oncol Res 16 2009 377 383
21. D.A. Thorley-Lawson, and A. Gross Persistence of the Epstein-Barr virus and the origins of associated lymphomas N Engl J Med 350 2004 1328 1337
22. G. Kelly, A. Bell, and A. Rickinson Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2 Nat Med 8 2002 1098 1104
23. K.D. Robertson, and R.F. Ambinder Methylation of the Epstein-Barr virus genome in normal lymphocytes Blood 90 1997 4480 4484
24. K.D. Robertson, S.D. Hayward, P.D. Ling, D. Samid, and R.F. Ambinder Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial Mol Cell Biol 15 1995 6150 6159
25. D. Salamon, M. Takacs, D. Ujvari, J. Uhlig, H. Wolf, J. Minarovits, and H.H. Niller Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus J Virol 75 2001 2584 2596
26. B.C. Schaefer, J.L. Strominger, and S.H. Speck Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs Mol Cell Biol 17 1997 364 377
27. E.J. Paulson, and S.H. Speck Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals J Virol 73 1999 9959 9968
28. C.L. Hsieh Evidence that protein binding specifies sites of DNA demethylation Mol Cell Biol 19 1999 46 56
29. T. Gunther, and A. Grundhoff The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes PLoS Pathog 6 2010 e1000935
30. F. Lu, W. Stedman, M. Yousef, R. Renne, and P.M. Lieberman Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway J Virol 84 2010 2697 2706
31. M.A. Dawson, and T. Kouzarides Cancer epigenetics: from mechanism to therapy Cell 150 2012 12 27
32. M. Shamay, A. Krithivas, J. Zhang, and S.D. Hayward Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA Proc Natl Acad Sci U S A 103 2006 14554 14559
33. S. Matsumura, L.M. Persson, L. Wong, and A.C. Wilson The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains J Virol 84 2009 2318 2330
34. K.S. Gray, J.C. Forrest, and S.H. Speck The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency J Virol 84 2010 4946 4959
35. M. Bergbauer, M. Kalla, A. Schmeinck, C. Gobel, U. Rothbauer, S. Eck, A. Benet-Pages, T.M. Strom, and W. Hammerschmidt CpG-methylation regulates a class of Epstein-Barr virus promoters PLoS Pathog 6 2010 e1001114
36. M. Kalla, A. Schmeinck, M. Bergbauer, D. Pich, and W. Hammerschmidt AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome Proc Natl Acad Sci U S A 107 2010 850 855
37. M. Kalla, C. Gobel, and W. Hammerschmidt The lytic phase of Epstein-Barr virus requires a viral genome with 5-methylcytosine residues in CpG sites J Virol 86 2011 447 458
38. A.J. Sinclair Unexpected structure of Epstein-Barr virus lytic cycle activator Zta Trends Microbiol 14 2006 289 291
39. Q.H. Karlsson, C. Schelcher, E. Verrall, C. Petosa, and A.J. Sinclair Methylated DNA recognition during the reversal of epigenetic silencing is regulated by cysteine and serine residues in the Epstein-Barr virus lytic switch protein PLoS Pathog 4 2008 e1000005
40. Q.H. Karlsson, C. Schelcher, E. Verrall, C. Petosa, and A.J. Sinclair The reversal of epigenetic silencing of the EBV genome is regulated by viral bZIP protein Biochem Soc Trans 36 2008 637 639
41. P.M. Bhende, W.T. Seaman, H.J. Delecluse, and S.C. Kenney The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome Nat Genet 36 2004 1099 1104
42. P.M. Bhende, W.T. Seaman, H.J. Delecluse, and S.C. Kenney BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186 J Virol 79 2005 7338 7348
43. S. Ramasubramanyan, A. Kanhere, K. Osborn, K. Flower, R.G. Jenner, and A.J. Sinclair Genome-wide analyses of zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile J Virol 86 2012 12494 12502
44. N. Alazard, H. Gruffat, E. Hiriart, A. Sergeant, and E. Manet Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin J Virol 77 2003 8166 8172
45. Z. Deng, C.J. Chen, M. Chamberlin, F. Lu, G.A. Blobel, D. Speicher, L.A. Cirillo, K.S. Zaret, and P.M. Lieberman The CBP bromodomain and nucleosome targeting are required for Zta-directed nucleosome acetylation and transcription activation Mol Cell Biol 23 2003 2633 2644
46. G. Miller, A. El-Guindy, J. Countryman, J. Ye, and L. Gradoville Lytic cycle switches of oncogenic human gammaherpesviruses(1) Adv Cancer Res 97 2007 81 109
47. F. Lu, J. Zhou, A. Wiedmer, K. Madden, Y. Yuan, and P.M. Lieberman Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency J Virol 77 2003 11425 11435
48. L. Day, C.M. Chau, M. Nebozhyn, A.J. Rennenkamp, M. Showe, and P.M. Lieberman Chromatin profiling of Epstein-Barr virus latency control region J Virol 81 2007 6389 63401
49. A. Arvey, I. Tempera, K. Tsai, H.S. Chen, N. Tikhmyanova, M. Klichinsky, C. Leslie, and P.M. Lieberman An atlas of the Epstein-barr virus transcriptome and epigenome reveals host-virus regulatory interactions Cell Host Microbe 12 2012 233 245
50. Z. Toth, D.T. Maglinte, S.H. Lee, H.R. Lee, L.Y. Wong, K.F. Brulois, S. Lee, J.D. Buckley, P.W. Laird, and V.E. Marquez Epigenetic analysis of KSHV latent and lytic genomes PLoS Pathog 6 2010 e1001013
51. B.E. Bernstein, T.S. Mikkelsen, X. Xie, M. Kamal, D.J. Huebert, J. Cuff, B. Fry, A. Meissner, M. Wernig, and K. Plath A bivalent chromatin structure marks key developmental genes in embryonic stem cells Cell 125 2006 315 326
52. J.E. Phillips, and V.G. Corces CTCF: master weaver of the genome Cell 137 2009 1194 1211
53. R. Ohlsson, V. Lobanenkov, and Klenova E Does CTCF mediate between nuclear organization and gene expression? Bioessays 32 2010 37 50
54. I. Tempera, A. Wiedmer, J. Dheekollu, and P.M. Lieberman CTCF prevents the epigenetic drift of EBV latency promoter Qp PLoS Pathog 2010 6
55. W. Stedman, H. Kang, S. Lin, J.L. Kissil, M.S. Bartolomei, and P.M. Lieberman Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators EMBO J 27 2008 654 666
56. T.M. Avolio-Hunter, P.N. Lewis, and L. Frappier Epstein-Barr nuclear antigen 1 binds and destabilizes nucleosomes at the viral origin of latent DNA replication Nucleic Acids Res 29 2001 3520 3528
57. T.M. Avolio-Hunter, and L. Frappier EBNA1 efficiently assembles on chromatin containing the Epstein-Barr virus latent origin of replication Virology 315 2003 398 408
58. J. Dheekollu, and P.M. Lieberman The replisome pausing factor Timeless is required for episomal maintenance of latent Epstein-Barr virus J Virol 85 2011 5853 5863
59. J. Dheekollu, H.S. Chen, K.M. Kaye, and P.M. Lieberman Timeless-dependent DNA replication-coupled recombination promote kshv episome maintenance and terminal repeat stability J Virol 87 2013 3699 3709
60. I. Tempera, M. Klichinsky, and P.M. Lieberman EBV latency types adopt alternative chromatin conformations PLoS Pathog 7 2011 e1002180
61. H. Kang, A. Wiedmer, Y. Yuan, E. Robertson, and P.M. Lieberman Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation PLoS Pathog 7 2011 e1002140
62. K. Nasmyth, and C.H. Haering The structure and function of SMC and kleisin complexes Annu Rev Biochem 74 2005 595 648
63. A. Losada Cohesin regulation: fashionable ways to wear a ring Chromosoma 116 2007 321 329
64. D. Dorsett Cohesin: genomic insights into controlling gene transcription and development Curr Opin Genet Dev 21 2011 199 206
65. R. Chien, W. Zeng, A.R. Ball, and K. Yokomori Cohesin: a critical chromatin organizer in mammalian gene regulation Biochem Cell Biol 89 2011 445 458
66. H.S. Chen, P. Wikramasinghe, L. Showe, and P.M. Lieberman Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency J Virol 86 2012 9454 9464
67. K. Paschos, and M.J. Allday Epigenetic reprogramming of host genes in viral and microbial pathogenesis Trends Microbiol 18 2010 439 447
68. A.L. Kirchmaier, and B. Sugden Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus J Virol 72 1998 4657 4666
69. L.R. Dresang, D.T. Vereide, and B. Sugden Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (EBNA1) in the human genome: defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes J Virol 83 2009 2930 2940
70. F. Lu, P. Wikramasinghe, J. Norseen, K. Tsai, P. Wang, L. Showe, R.V. Davuluri, and P.M. Lieberman Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) Virol J 7 2010 262
71. I.K. Ruf, A. Moghaddam, F. Wang, and J. Sample Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates J Virol 73 1999 1980 1989
72. M. Altmann, D. Pich, R. Ruiss, J. Wang, B. Sugden, and W. Hammerschmidt Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes Proc Natl Acad Sci U S A 103 2006 14188 14193
73. B. Gruhne, R. Sompallae, D. Marescotti, S.A. Kamranvar, S. Gastaldello, and M.G. Masucci The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species Proc Natl Acad Sci U S A 106 2009 2313 2318
74. S. Wang, and L. Frappier Nucleosome assembly proteins bind to Epstein-Barr virus nuclear antigen 1 and affect its functions in DNA replication and transcriptional activation J Virol 83 2009 11704 11714
75. I. Tempera, Z. Deng, C. Atanasiu, C.J. Chen, M. D'Erme, and P.M. Lieberman Regulation of Epstein-Barr virus OriP replication by poly(ADP-ribose) polymerase 1 J Virol 84 2010 4988 4997
76. Z. Deng, C. Atanasiu, K. Zhao, R. Marmorstein, J.I. Sbodio, N.W. Chi, and P.M. Lieberman Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1 J Virol 79 2005 4640 4650
77. M.E. Ballestas, and K.M. Kaye The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency Future Microbiol 6 2011 1399 1413
78. F. Lu, K. Tsai, H.S. Chen, P. Wikramasinghe, R.V. Davuluri, L. Showe, J. Domsic, R. Marmorstein, and P.M. Lieberman Identification of host-chromosome binding sites and candidate gene targets for KSHV LANA J Virol 86 2012 5752 5762
79. Y. Jin, Z. He, D. Liang, Q. Zhang, H. Zhang, Q. Deng, E.S. Robertson, and K. Lan LANA carboxyl terminal amino acids 1052 to 1082 interact with RBP-Jkappa and are responsible for LANA-mediated RTA repression J Virol 86 2012 4956 4969
80. J. Lu, S.C. Verma, Q. Cai, and E.S. Robertson The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection J Virol 85 2011 6148 6161
81. K. Lan, D.A. Kuppers, and E.S. Robertson Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway J Virol 79 2005 3468 3478
82. J. Lu, S.C. Verma, Q. Cai, A. Saha, R.K. Dzeng, and E.S. Robertson The RBP-Jkappa binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation PLoS Pathog 8 2012 e1002479
83. A.J. Barbera, J.V. Chodaparambil, B. Kelley-Clarke, V. Joukov, J.C. Walter, K. Luger, and K.M. Kaye The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA Science 311 2006 856 861
84. M. Ottinger, T. Christalla, K. Nathan, M.M. Brinkmann, A. Viejo-Borbolla, and T.F. Schulz Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest J Virol 80 2006 10772 10786
85. A. Krithivas, M. Fujimuro, M. Weidner, D.B. Young, and S.D. Hayward Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes J Virol 76 2002 11596 11604
86. G. Sarek, A. Jarviluoma, H.M. Moore, S. Tojkander, S. Vartia, P. Biberfeld, M. Laiho, and P.M. Ojala Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency PLoS Pathog 6 2010 e1000818
87. B. Xiao, S.C. Verma, Q. Cai, R. Kaul, J. Lu, A. Saha, and E.S. Robertson Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores J Virol 84 2010 9718 9732
88. M. Shamay, J. Liu, R. Li, G. Liao, L. Shen, M. Greenway, S. Hu, J. Zhu, X. Zhi, and R.F. Ambinder A protein array screen for KSHV LANA interactors links LANA to TIP60, PP2A activity and telomere shortening J Virol 86 2012 5179 5191
89. W. Chen, I.B. Hilton, M.R. Staudt, C.E. Burd, and D.P. Dittmer Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma - associated Herpesvirus Lymphomas J Virol 84 2010 3898 3908
90. P. Purushothaman, M.E. McDowell, J. McGuinness, R. Salas, S.M. Rumjahn, and S.C. Verma Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIbeta for latent DNA replication of the terminal repeats J Virol 86 2012 9983 9994
91. F. Lu, L. Day, S.J. Gao, and P.M. Lieberman Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription J Virol 80 2006 5273 5282
92. M. Campbell, P.C. Chang, S. Huerta, C. Izumiya, R. Davis, C.G. Tepper, K.Y. Kim, B. Shevchenko, D.H. Wang, and J.U. Jung Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen J Biol Chem 287 2011 5806 5818
93. F. Cheng, M. Weidner-Glunde, M. Varjosalo, E.M. Rainio, A. Lehtonen, T.F. Schulz, P.J. Koskinen, J. Taipale, and P.M. Ojala KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA PLoS Pathog 5 2009 e1000324
94. B.G. Bajaj, S.C. Verma, K. Lan, M.A. Cotter, Z.L. Woodman, and E.S. Robertson KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity Virology 351 2006 18 28
95. C. Woodard, M. Shamay, G. Liao, J. Zhu, A.N. Ng, R. Li, R. Newman, H.S. Rho, J. Hu, and J. Wan Phosphorylation of the chromatin binding domain of KSHV LANA PLoS Pathog 8 2012 e1002972
96. N. Sivachandran, J.Y. Cao, and L. Frappier Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies J Virol 84 2010 11113 11123
97. M.S. Kang, E.K. Lee, V. Soni, T.A. Lewis, A.N. Koehler, V. Srinivasan, and E. Kieff Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenance J Virol 85 2011 2859 2868
98. V. Saridakis, Y. Sheng, F. Sarkari, M.N. Holowaty, K. Shire, T. Nguyen, R.G. Zhang, J. Liao, W. Lee, and A.M. Edwards Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization Mol Cell 18 2005 25 36
99. W. Jager, S. Santag, M. Weidner-Glunde, E. Gellermann, S. Kati, M. Pietrek, A. Viejo-Borbolla, and T.F. Schulz The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA J Virol 86 2012 6745 6757
100. F. Sarkari, X. Wang, T. Nguyen, and L. Frappier The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies PLoS One 6 2011 e16598
101. J. Sears, M. Ujihara, S. Wong, C. Ott, J. Middeldorp, and A. Aiyar The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes J Virol 78 2004 11487 11505
102. V.K. Nayyar, K. Shire, and L. Frappier Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2) J Cell Sci 122 2009 4341 4350
103. A. Lin, S. Wang, T. Nguyen, K. Shire, and L. Frappier The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4 J Virol 82 2008 12009 12019
104. A. Viejo-Borbolla, M. Ottinger, E. Bruning, A. Burger, R. Konig, E. Kati, J.A. Sheldon, and T.F. Schulz Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1 J Virol 79 2005 13618 13629
105. P. Filippakopoulos, and S. Knapp The bromodomain interaction module FEBS Lett 586 2012 2692 2704
106. J. You, J.L. Croyle, A. Nishimura, K. Ozato, and P.M. Howley Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes Cell 117 2004 349 360
107. E.A. Abbate, C. Voitenleitner, and M.R. Botchan Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association Mol Cell 24 2006 877 889
108. S.Y. Wu, A.Y. Lee, S.Y. Hou, J.K. Kemper, H. Erdjument-Bromage, P. Tempst, and C.M. Chiang Brd4 links chromatin targeting to HPV transcriptional silencing Genes Dev 20 2006 2383 2396
109. M.G. McPhillips, J.G. Oliveira, J.E. Spindler, R. Mitra, and A.A. McBride Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses J Virol 80 2006 9530 9543
110. S.Y. Wu, and C.M. Chiang The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation J Biol Chem 282 2007 13141 13145
111. B.N. Devaiah, and D.S. Singer Two faces of BRD4: mitotic bookmark and transcriptional lynchpin Transcription 2012 4
112. P. Voigt, and D. Reinberg BRD4 jump-starts transcription after mitotic silencing Genome Biol 12 2011 133
113. P.S. Moore, and Y. Chang Why do viruses cause cancer?, Highlights of the first century of human tumour virology Nat Rev Cancer 10 2010 878 889